The Danish pharma company announced this morning that it will roll out what its calling the first multimonth subscription program for an FDA-approved obesity drug, offering Wegovy at a fixed monthly price that features savings of up to $1,200 a year for self-pay patients
Breakthrough bleeding Breakthrough bleeding, or spotting between periods, may happen if youre taking Zepbound, Saxenda, or another GLP-1
Ethics statement The studies involving humans were approved by EudraCT No: 2015-001628-45
For them, starting a GLP1 can be the first time they experience that sensation. Do GLP-1s work differently in women and men
This is a critical issue for anyone ordering compounded tirzepatide
Some platforms focus on speed and prescription access, while others pair medication with behavioral guidance, nutrition tools, and coaching